GOSSAMER BIO, INC. (GOSS) Operating cash flow 2017–2025
GOSSAMER BIO, INC. (GOSS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$171.3MFY2025 · since FY2017: -$5.7M → -$171.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$171.3M | -4838.5% |
| FY2024 | -$3.5M | +97.8% |
| FY2023 | -$159.2M | +14.9% |
| FY2022 | -$187.0M | +1.0% |
| FY2021 | -$188.9M | -7.1% |
| FY2020 | -$176.4M | -21.8% |
| FY2019 | -$144.8M | -183.7% |
| FY2018 | -$51.0M | -788.5% |
| FY2017 | -$5.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GOSS financial trends
GOSS RevenueGOSS Net incomeGOSS Net marginGOSS Gross profitGOSS Gross marginGOSS Operating incomeGOSS Operating marginGOSS Free cash flowGOSS Capital expendituresGOSS Return on equityGOSS Stock buybacksGOSS Dividends paidGOSS Total assetsGOSS Total liabilitiesGOSS Shareholders’ equityGOSS overview →